Celldex Therapeutics Inc. (CLDX) Surged 7.47% or 0.02 To Price $0.31 On Thursday


Celldex Therapeutics Inc. (CLDX) surged 7.47% or 0.02 to $0.31. It is approximately 1.17 million shares traded, which is 60.97% compare to the average total volume 1.93 million. The market cap of CLDX is $54.31 million. The year to date change is -82.49%. The 52 week price range is from $0.28 to $3.09. Price of CLDX have changed -4.25% during last week. It have changed -9.01% over last month, -41.39% over last 3 months, -53.30% over last 6 months and -90.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 0.38. It is 22.58% above current price. The 200-day Moving Averages for CLDX is 0.91. It is 193.55% above current price. The 52-week High is 3.09. It is 896.77% from the current price. The 52-week Low is 0.28. It is -9.68% from current price.

There are some statistics of CLDX. It is has market cap $54.31 million. The share outstanding is 172.47 million. The average volume is 1.93 million. The percent of top 15 Institution holding is 48.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -84.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -60.12%.


Tags:

Share this post